Lipidomic profiling of chorionic villi in the placentas of women with chronic venous disease

Background: Chronic venous disease (CVD) is a prevalent lower limb venous pathology that especially affects women, who also show an increased risk of this disease during pregnancy. Studies have shown significant structural changes in the placentas of women with CVD and several markers of tissue damage have been also described. Patients and Methods: To try to understand the different placental pathologies, research efforts have focused on examining metabolomic profiles as indicators of the repercussions of these vascular disorders. This study examines changes produced in the metabolomic profiles of chorionic villi in the placentas of women with CVD. In a study population of 12 pregnant women, 6 with and 6 without CVD, we compared through mass spectroscopy coupled to ultra-high performance liquid chromatography (UHPLC-MS), 240 metabolites in chorionic villus samples. Results: This study is the first to detect in the placental villi of pregnant women with CVD, modifications in lysophosphatidylcholines and amino acids along with diminished levels of other lipids such as triglycerides, sphingomyelins, and non-esterified omega 9 fatty acids, suggesting a role of these abnormalities in the pathogenesis of CVD. Conclusions: Our findings are a starting point for future studies designed to examine the impacts of CVD on maternal and fetal well-being.

[1]  Y. Hannun Functions of Ceramide in Coordinating Cellular Responses to Stress , 1996, Science.

[2]  B. Strandvik,et al.  Composition and permeability of syncytiotrophoblast plasma membranes in pregnancies complicated by intrauterine growth restriction. , 1999, Biochimica et biophysica acta.

[3]  P. Allan,et al.  Lifestyle risk factors for lower limb venous reflux in the general population: Edinburgh Vein Study. , 2001, International journal of epidemiology.

[4]  W. Foulkes Of mice and women. , 2002, Cancer cell.

[5]  Norbert G. Benesh,et al.  Varicose Veins , 1929, Circulation.

[6]  Volker Wulf,et al.  Applications of IT , 2004 .

[7]  M. Rantalainen,et al.  OPLS discriminant analysis: combining the strengths of PLS‐DA and SIMCA classification , 2006 .

[8]  E. J. Singh,et al.  The phospholipid composition of human placenta, endometrium and amniotic fluid: A comparative study , 2006, Lipids.

[9]  W. Griffiths,et al.  Metabolomics and Metabolite Profiling: Past Heroes and Future Developments , 2007, European journal of mass spectrometry.

[10]  U. Edlund,et al.  Visualization of GC/TOF-MS-based metabolomics data for identification of biochemically interesting compounds using OPLS class models. , 2008, Analytical chemistry.

[11]  L. Sumner,et al.  Current and emerging mass-spectrometry technologies for metabolomics , 2008 .

[12]  Gordana Ivosev,et al.  Instrumental and experimental effects in LC-MS-based metabolomics. , 2008, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[13]  I. Wilson,et al.  LC-MS-based methodology for global metabolite profiling in metabonomics/metabolomics , 2008 .

[14]  E. Stranden,et al.  [Venous insufficiency in the lower limbs]. , 2009, Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke.

[15]  Frans M van der Kloet,et al.  Analytical error reduction using single point calibration for accurate and precise metabolomic phenotyping. , 2009, Journal of proteome research.

[16]  Heng Tao Shen,et al.  Principal Component Analysis , 2009, Encyclopedia of Biometrics.

[17]  Shelly C. Lu,et al.  Liquid chromatography-mass spectrometry-based parallel metabolic profiling of human and mouse model serum reveals putative biomarkers associated with the progression of nonalcoholic fatty liver disease. , 2010, Journal of proteome research.

[18]  M. Baker Metabolomics: from small molecules to big ideas , 2011, Nature Methods.

[19]  Sónia Carneiro,et al.  The biological interpretation of metabolomic data can be misled by the extraction method used , 2012, Metabolomics.

[20]  W. Miller,et al.  Early steps in steroidogenesis: intracellular cholesterol trafficking , 2011, Journal of Lipid Research.

[21]  B. Sibai,et al.  Maternal mortality from preeclampsia/eclampsia. , 2012, Seminars in perinatology.

[22]  Shelly C. Lu,et al.  Obesity-dependent metabolic signatures associated with nonalcoholic fatty liver disease progression. , 2012, Journal of proteome research.

[23]  D. Ingram,et al.  Chronic caloric restriction partially protects against age-related alteration in serum metabolome , 2012, AGE.

[24]  E. Rabe,et al.  Clinical, Aetiological, Anatomical and Pathological Classification (Ceap): Gold Standard and Limits , 2012, Phlebology.

[25]  M. Ropacka-Lesiak,et al.  [Risk factors for the development of venous insufficiency of the lower limbs during pregnancy--part 1]. , 2012, Ginekologia polska.

[26]  D. Sokolović,et al.  Arginase Activity and Lecithin/Sphingomyelin (L/S) Ratio in the Amniotic Fluid of Pregnant Women , 2013, Indian Journal of Clinical Biochemistry.

[27]  M. Choolani,et al.  Lipidomic analysis of human placental syncytiotrophoblast microvesicles in adverse pregnancy outcomes. , 2013, Placenta.

[28]  Age K. Smilde,et al.  Reflections on univariate and multivariate analysis of metabolomics data , 2013, Metabolomics.

[29]  C. Sibley,et al.  Review: Transport across the placenta of mice and women. , 2013, Placenta.

[30]  N. Câmara,et al.  Lipidomic Assessment of Plasma and Placenta of Women with Early-Onset Preeclampsia , 2014, PloS one.

[31]  J. Raffetto,et al.  Pathophysiology of chronic venous disease. , 2014, International angiology : a journal of the International Union of Angiology.

[32]  R. Romero,et al.  Pre-eclampsia part 1: current understanding of its pathophysiology , 2014, Nature Reviews Nephrology.

[33]  M. Setou,et al.  Decrease in Sphingomyelin (d18:1/16:0) in Stem Villi and Phosphatidylcholine (16:0/20:4) in Terminal Villi of Human Term Placentas with Pathohistological Maternal Malperfusion , 2015, PloS one.

[34]  Ibon Martínez-Arranz,et al.  Enhancing metabolomics research through data mining. , 2015, Journal of proteomics.

[35]  L. Ermini,et al.  Disruption of sphingolipid metabolism augments ceramide-induced autophagy in preeclampsia , 2015, Autophagy.

[36]  S. Weiss,et al.  Integration of metabolomic and transcriptomic networks in pregnant women reveals biological pathways and predictive signatures associated with preeclampsia , 2016, Metabolomics.

[37]  Bruce J. Jackson,et al.  Detection and confirmation of serum lipid biomarkers for preeclampsia using direct infusion mass spectrometry[S] , 2016, Journal of Lipid Research.

[38]  T. Mitchell,et al.  A Lipidomic Analysis of Placenta in Preeclampsia: Evidence for Lipid Storage , 2016, PloS one.

[39]  G. Burton,et al.  Placental Origins of Chronic Disease. , 2016, Physiological reviews.

[40]  S. Lorkowski,et al.  Individual omega-9 monounsaturated fatty acids and mortality-The Ludwigshafen Risk and Cardiovascular Health Study. , 2017, Journal of clinical lipidology.

[41]  S. Weiss,et al.  Applications of metabolomics in the study and management of preeclampsia: a review of the literature , 2017, Metabolomics.

[42]  J. Buján,et al.  Implication of the PI3K/Akt/mTOR Pathway in the Process of Incompetent Valves in Patients with Chronic Venous Insufficiency and the Relationship with Aging , 2018, Oxidative medicine and cellular longevity.

[43]  Data , 2018, Nature.

[44]  B. Nora,et al.  [An update on the treatment of venous insufficiency in pregnancy]. , 2017, Semergen.

[45]  J. Buján,et al.  Unravelling the Role of MAPKs (ERK1/2) in Venous Reflux in Patients with Chronic Venous Disorder , 2019, Cells Tissues Organs.

[46]  I. Ellinger,et al.  Physiology and Pathophysiology of Steroid Biosynthesis, Transport and Metabolism in the Human Placenta , 2018, Front. Pharmacol..

[47]  J. Buján,et al.  Remodelling of collagen fibres in the placentas of women with venous insufficiency during pregnancy. , 2018, Histology and histopathology.

[48]  M. Sperandio,et al.  Omega-9 Oleic Acid, the Main Compound of Olive Oil, Mitigates Inflammation during Experimental Sepsis , 2018, Oxidative medicine and cellular longevity.

[49]  J. Buján,et al.  Behavior of Smooth Muscle Cells under Hypoxic Conditions: Possible Implications on the Varicose Vein Endothelium , 2018, BioMed research international.

[50]  L. Barberini,et al.  Preliminary metabolomics analysis of placenta in maternal obesity. , 2018, Placenta.

[51]  J. Buján,et al.  Placentas from women with pregnancy-associated venous insufficiency show villi damage with evidence of hypoxic cellular stress. , 2018, Human pathology.

[52]  Bo Li,et al.  In vitro fertilization alters phospholipid profiles in mouse placenta , 2019, Journal of Assisted Reproduction and Genetics.

[53]  J. Buján,et al.  Upregulation of VEGF and PEDF in Placentas of Women with Lower Extremity Venous Insufficiency during Pregnancy and Its Implication in Villous Calcification , 2019, BioMed research international.

[54]  Y. Youn,et al.  Chronic venous insufficiency and varicose veins of the lower extremities , 2018, The Korean journal of internal medicine.

[55]  J. Buján,et al.  Patients with Incompetent Valves in Chronic Venous Insufficiency Show Increased Systematic Lipid Peroxidation and Cellular Oxidative Stress Markers , 2019, Oxidative medicine and cellular longevity.

[56]  J. Buján,et al.  Pregnancy‐associated venous insufficiency course with placental and systemic oxidative stress , 2020, Journal of cellular and molecular medicine.

[57]  M. Bennett,et al.  The Metabolomic Signature of the Placenta in Spontaneous Preterm Birth , 2020, International journal of molecular sciences.

[58]  J. Buján,et al.  Increased Angiogenesis and Lymphangiogenesis in the Placental Villi of Women with Chronic Venous Disease during Pregnancy , 2020, International journal of molecular sciences.